Affymetrix Enters Settlement Agreement with Shareholders over Derivative Suit | GenomeWeb

NEW YORK (GenomeWeb News) – Affymetrix disclosed in a filing with the US Securities and Exchange Commission today that it has entered into a settlement agreement regarding litigation with shareholders who had sued certain executives of the company for allegedly back-dating stock options and pocketing "hundreds of millions of dollars of corporate assets."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.